Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
12/2014
12/10/2014CN104193684A 4-氨基安替比林缩2,5-二羟基苯甲醛席夫碱及应用 4-amino-antipyrine shrink 2,5 dihydroxybenzaldehyde Schiff base and application
12/10/2014CN104193683A 含二氯丙烯的吡唑肟衍生物及其制备和应用方法 Dichloropropene containing pyrazole oxime derivatives, preparation and application methods
12/10/2014CN104193682A 唑菌酯的荧光标记方法及其应用 Fluorescent labeling method and its application azole bacteria ester
12/10/2014CN104193681A 4-氯-3-乙基-1-甲基-n'-(2-取代苯氧乙酰基)-1h-吡唑-5-碳酰肼类化合物的制备与应用 4-chloro-3-ethyl-1-methyl -n '- (2- substituted phenoxy-acetyl) -1h- pyrazol-5 Preparation and Application of carbohydrazide Compounds
12/10/2014CN102898373B Z-3-酰氧基-3-(1-乙基吡唑基)丙烯腈类化合物的制备方法 Preparation Z-3- acyloxy-3- (1-ethyl-pyrazol-yl) acrylonitrile compounds
12/10/2014CN102858735B N-甲氧羰基-n-甲氧基-(2-氯甲基)苯胺、其制备及其作为制备2-(吡唑-3＇-基氧基亚甲基)酰替苯胺的前体的用途 N- (methoxycarbonyl) -n- methoxy - (2-chloro-methyl) aniline, their preparation and their use as Preparation of 2- (pyrazol-3'-yl) -1,6-acyl aniline precursors for the use
12/09/2014US8907110 Benzodioxepin-3-one compounds as dyes or as fluorescent emitters
12/09/2014US8907104 Synthesis of enone intermediate
12/09/2014US8906887 C7-fluoro substituted tetracycline compounds
12/09/2014US8906647 Diamide inhibitors of cytochrome P450
12/04/2014US20140357872 New organocatalytic synthesis of chiral pyrazolidines and their analogues
12/02/2014US8901316 Process for preparing aminoadamantyl carbamate derivatives
12/02/2014US8901315 Thienopyrazole derivative having PDE7 inhibitory activity
12/02/2014US8901314 Substituted pyrazoles as N-type calcium channel blockers
12/02/2014US8901295 Inhibitors of cyclophilins and uses thereof
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901108 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
11/2014
11/27/2014US20140350267 Process for the preparation of n-substituted pyrazole compounds
11/27/2014US20140350012 Piperidine/piperazine derivatives
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/25/2014US8895757 Process for the preparation of pyrazole carboxylic acid amides
11/25/2014US8895755 Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
11/25/2014US8895603 Crystalline forms of a dipeptidyl peptidase-IV inhibitor
11/25/2014US8895601 Pyrazolyl quinoxaline kinase inhibitors
11/25/2014US8895589 Pyridinyl amides as P2X3 and P2X2/3 inhibitors
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8894971 Iodine radiolabelling method
11/20/2014US20140343294 Pharmaceutical compounds
11/20/2014US20140343113 Fungicidal n-bicycloalkyl and n-tricycloalkyl pyrazole-4-(thio)carboxamide derivatives
11/20/2014US20140343037 Benzene, pyridine, and pyridazine derivatives
11/18/2014US8889906 Tetralin and indane derivatives and uses thereof
11/18/2014US8889732 Fused heterocyclic compounds and thrombopoietin receptor activators
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889727 Topical antifungal agent
11/13/2014US20140336440 Inhibitors of rho associated protein kinases (rock) and methods of use
11/13/2014US20140336224 Mineralocorticoid receptor antagonists
11/13/2014US20140336194 Method of treating contrast-induced nephropathy
11/13/2014US20140336170 Indazole compounds useful as ketohexokinase inhibitors
11/11/2014US8884028 Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
11/11/2014US8883786 Glucocorticoid receptor antagonists
11/06/2014US20140329875 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
11/06/2014US20140329817 Myxovirus therapeutics, compounds, and uses related thereto
11/04/2014US8877971 Method for preparing formamide compounds
11/04/2014US8877795 Identification of stabilizers of multimeric proteins
11/04/2014US8877794 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/04/2014US8877786 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
11/04/2014US8877753 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/2014
10/30/2014US20140323538 Anticancer p21-activated kinase inhibitors
10/30/2014US20140323537 Arginine methyltransferase inhibitors and uses thereof
10/30/2014US20140323485 N-Substituted Heterocyclyl Carboxamides
10/30/2014US20140323475 Ep1 receptor ligands
10/28/2014US8871947 Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester
10/28/2014US8871939 Method for preparing 2-aminobenzamide derivatives
10/28/2014US8871797 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871792 Neprilysin inhibitors
10/28/2014US8871747 Urea and thiourea derivatives
10/23/2014US20140315971 Pyrazole compound
10/23/2014US20140315961 Arginine methyltransferase inhibitors and uses thereof
10/23/2014US20140315959 Treatment of ovarian cancer with benzylidenebenzohydrazides
10/23/2014US20140315945 Substituted Benzene Compounds
10/23/2014US20140315933 Chemical compounds
10/23/2014US20140315904 Arginine methyltransferase inhibitors and uses thereof
10/23/2014US20140315889 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
10/21/2014US8865758 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
10/21/2014US8865754 Compounds for the treatment of neurodegenerative diseases
10/21/2014US8865751 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/21/2014US8865738 5-membered heterocyclic compound cyclopenta[C]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
10/21/2014US8865736 Antibacterial agents
10/21/2014US8864848 Zwitterionic azo dyestuffs for coloring keratin-including fibres
10/16/2014US20140309206 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
10/16/2014US20140309200 Methods and Compositions for Enhanced Drug Delivery to the Eye and Extended Delivery Formulations
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859781 No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents
10/14/2014US8859607 Crystalline complexes of agriculturally active organic compounds
10/14/2014US8859606 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
10/14/2014US8859605 Cysteine protease inhibitors
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859591 Glucagon receptor modulators
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014US20140303372 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303175 2-Substituted-3-Phenylpropionic Acid Derivatives and Their Use in the Treatment of Inflammatory Bowel Disease
10/09/2014US20140303160 Targeting GLI Proteins in Human Cancer by Small Molecules
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2785698A2 Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives
10/08/2014EP2785697A1 N-(1h-pyrazolylmethyl)formamides, process for the preparation thereof and use thereof as nitrification inhibitors
10/08/2014EP2785696A1 Novel compounds
10/07/2014US8853427 Neprilysin inhibitors
10/07/2014US8853418 Cyclopentylpyrazoles as N-type calcium channel blockers
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853258 C-linked hydroxamic acid derivatives useful as antibacterial agents
10/07/2014US8853252 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/07/2014US8853205 Heteropyrrole analogs acting on cannabinoid receptors
10/07/2014US8853196 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
10/02/2014WO2014160181A1 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
10/02/2014WO2014158654A1 Ship1 modulators and methods related thereto
10/02/2014WO2014154682A1 Novel viral replication inhibitors
10/02/2014US20140296316 Hydrate and crystal of fluorene compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 256